New drugs approved by the FDA in 2025: Synthesis and clinical applications.

Liu W, Li X, Han Y, Wu L, Wang M, Xuan W, Xu Z, Liu W, Zhao Q, Hao S

Open source

DOI
10.1016/j.ejmech.2026.118952
Published
2026 Oct 5
Container
European journal of medicinal chemistry
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2026.118952,
  title = {New drugs approved by the FDA in 2025: Synthesis and clinical applications.},
  author = {Liu W and Li X and Han Y and Wu L and Wang M and Xuan W and Xu Z and Liu W and Zhao Q and Hao S},
  year = {2026},
  journal = {European journal of medicinal chemistry},
  doi = {10.1016/j.ejmech.2026.118952},
  url = {https://doi.org/10.1016/j.ejmech.2026.118952}
}

RIS

TY  - JOUR
TI  - New drugs approved by the FDA in 2025: Synthesis and clinical applications.
AU  - Liu W
AU  - Li X
AU  - Han Y
AU  - Wu L
AU  - Wang M
AU  - Xuan W
AU  - Xu Z
AU  - Liu W
AU  - Zhao Q
AU  - Hao S
PY  - 2026
JO  - European journal of medicinal chemistry
DO  - 10.1016/j.ejmech.2026.118952
UR  - https://doi.org/10.1016/j.ejmech.2026.118952
ER  - 

APA

W, L., X, L., Y, H., L, W., M, W., W, X., Z, X., W, L., Q, Z., & S, H. (2026). New drugs approved by the FDA in 2025: Synthesis and clinical applications.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2026.118952

Source records